1. Not yet
recruiting Iressa/Docetaxel
in Non-Small-Cell Lung Cancer
2. Recruiting Docetaxel
With or Without Oblimersen in Treating Patients With Non-Small Cell
Lung Cancer
3. Recruiting Thalidomide
and Docetaxel in Treating Patients With Advanced Cancer
4. Recruiting Mitoxantrone
With or Without Docetaxel in Treating Women With Metastatic Breast
Cancer
5. Recruiting Paclitaxel
or Docetaxel in Treating Women With Advanced Breast Cancer
6. Recruiting Erlotinib,
Docetaxel, and Radiation Therapy in Treating Patients With Locally
Advanced Head and Neck Cancer
7. Recruiting Docetaxel
in Treating Patients Who Have Undergone Surgery for Prostate Cancer
8. Recruiting CT-2103
Compared With Docetaxel in Treating Patients With Progressive
Non-Small Cell Lung Cancer
9. Recruiting Chemotherapy
With or Without Docetaxel Plus Radiation Therapy in Treating
Patients With Stage III or Stage IV Head and Neck Cancer
10. Recruiting PS-341
and Docetaxel in Treating Patients With Advanced Solid Tumors
11. Recruiting Docetaxel
With or Without Infliximab in Treating Weight Loss, Loss of
Appetite, and Fatigue in Patients with Advanced Non-Small Cell Lung
Cancer
12. Recruiting Erlotinib
Plus Docetaxel in Treating Patients With Stage IV or Recurrent
Breast Cancer
13. Recruiting Docetaxel
and Trastuzumab With or Without Carboplatin in Treating Women With
HER2-Positive Breast Cancer
14. Recruiting Phase
1-2a Dose-Ranging Study of TLK286 in Combination with Docetaxel in
Platinum-Resistant Non-Small Cell Lung Cancer
15. Recruiting Docetaxel
in Treating Children With Relapsed or Refractory Leukemia
16. Recruiting Comparison
Study of MDX-010 Alone and Combined with Docetaxel in the Treatment
of Patients with Hormone Refractory Prostate Cancer
17. Recruiting Therapy
with docetaxel and ZD1839 for Patients who have advanced breast
cancer
18. Recruiting Docetaxel
in Treating Patients With Solid Tumors
19. Not yet
recruiting Docetaxel
and St. John's Wort in Treating Patients With Solid Tumors That
Cannot Be Removed By Surgery
20. Recruiting Docetaxel,
Estramustine, and Exisulind in Treating Patients With Metastatic
Prostate Cancer That Has Not Responded to Hormone Therapy
21. Not yet
recruiting Irinotecan
and Docetaxel With or Without Cetuximab in Treating Patients With
Metastatic Pancreatic Cancer
22. Recruiting Epirubicin
Combined With Docetaxel Before Surgery in Treating Women With Early
Breast Cancer
23. Recruiting Epirubicin
and Tamoxifen With or Without Docetaxel in Treating Postmenopausal
Women With Breast Cancer
24. Recruiting Docetaxel
or Paclitaxel in Treating Women With Unresectable Locally Advanced
or Metastatic Breast Cancer
25. Recruiting Docetaxel
in Treating Women With Ovarian Epithelial or Primary Peritoneal
Cancer
26. Recruiting SGN-15
And Docetaxel in Treating Patients With Advanced or Recurrent
Non-Small Cell Lung Cancer
27. Recruiting Docetaxel
With or Without Bevacizumab Followed by Surgery, Radiation Therapy,
and Combination Chemotherapy in Treating Patients With Locally
Advanced Breast Cancer
28. Recruiting Docetaxel,
Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast
Cancer
29. Recruiting Trastuzumab,
Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage
IV Breast Cancer
30. Recruiting Estramustine,
Docetaxel, and Carboplatin in Treating Patients With Prostate Cancer
That Has Not Responded to Hormone Therapy
31. Recruiting Docetaxel
Plus Carboplatin in Treating Patients With Stage III or Stage IV
Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
32. Recruiting ZD6474
and Docetaxel in Treating Patients With Locally Advanced or
Metastatic Non-Small Cell Lung Cancer
33. Recruiting Gemcitabine,
Docetaxel, and Filgrastim in Treating Patients With Recurrent or
Persistent Leiomyosarcoma or Soft Tissue Sarcoma
34. Recruiting Docetaxel
and Ifosfamide in Treating Women With Metastatic Breast Cancer
35. Recruiting Docetaxel
in Treating Patients With Metastatic Breast Cancer
36. Not yet
recruiting Docetaxel
and Capecitabine in Treating Patients With Metastatic Cancer of the
Stomach or Lower Esophagus
37. Recruiting Docetaxel
in Treating Patients With Persistent or Recurrent Cervical Cancer
38. Recruiting Flavopiridol
and Docetaxel in Treating Patients With Advanced Solid Tumors
39. Recruiting Vinorelbine
Followed by Docetaxel in Treating Patients With Advanced Non-Small
Cell Lung Cancer
40. Recruiting Gemcitabine
Plus Docetaxel in Treating Patients With Unresectable or Metastatic
Liver Cancer
41. Recruiting Docetaxel,
Estramustine, and Thalidomide in Treating Patients With Prostate
Cancer Previously Treated With Hormone Therapy
42. Recruiting Celecoxib
and Docetaxel in Treating Patients With Non-Small Cell Lung Cancer
43. Recruiting Docetaxel
in Treating Patients With Non-Small Cell Lung Cancer
44. Recruiting Sulindac
and Docetaxel in Treating Women With Metastatic or Recurrent Breast
Cancer
45. Recruiting Irinotecan
and Docetaxel in Treating Patients With Metastatic or Locally
Recurrent Head and Neck Cancer
46. Recruiting Docetaxel
in Treating Older Women With Metastatic Breast Cancer
47. No
longer recruiting Treatment
of Prostate Cancer with Docetaxel Alone and in Combination with
Thalidomide
48. Recruiting Comparison
PSA Vaccine Alone or Vaccine with Docetaxel for Treating Prostate
Cancer
49. Recruiting Docetaxel
With or Without Exisulind in Treating Patients With Non-Small Cell
Lung Cancer
50. Recruiting Safety/Efficacy
study of immunoconjugate with docetaxel in non-small cell lung
carcinoma
